City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border 		  
  PROFILE 
The following is a list of available studies directed by  Lily Lai, MD  
Search results:  3  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-3 Trials Jump to page:

COH Protocol Number: 11122

Principal Investigator: Lily Lai, MD
Sponsor: Industrial

Title:  A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint

COH Protocol Number: 09131 ClinicalTrials.gov Number: NCT00769379

Principal Investigator: Lily Lai, MD
Sponsor: Cooperative Group

Title:  NSABP B-43: A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy

COH Protocol Number: 05130

Principal Investigator: Lily Lai, MD
Sponsor: Institutional

Title:  Evaluation of Colon/Rectal Cancer Patterns and Outcomes of Care

 
Results per page: 25 50 100 All 1-3 Trials Jump to page:

 
 
  
© 2009 City of Hope.
1500 East Duarte Road
Duarte, California 91010
626-256-HOPE (4673)
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.